![]() |
市場調查報告書
商品編碼
1957158
無線腦電感測器市場-全球產業規模、佔有率、趨勢、機會、預測:按產品、應用、最終用途、地區和競爭對手分類,2021-2031年Wireless Brain Sensors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End Use, By Region & Competition, 2021-2031F |
||||||
全球無線腦感測器市場預計將從 2025 年的 5.6055 億美元成長到 2031 年的 9.5102 億美元,複合年成長率達到 9.21%。
這些專用醫療設備旨在無需與外部設備進行物理連接即可追蹤顱內壓和神經電活動。該領域的成長主要受全球神經系統疾病發病率上升以及對攜帶式、連續病患監測系統以實現居家醫療的需求所驅動。對先進診斷解決方案的迫切需求源於全球巨大的疾病負擔。根據世界衛生組織(世衛組織)2024年報告,神經系統疾病影響全球超過30億人,是造成殘疾和疾病的主要原因之一。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 5.6055億美元 |
| 市場規模:2031年 | 951,020,000 美元 |
| 複合年成長率:2026-2031年 | 9.21% |
| 成長最快的細分市場 | 失智症 |
| 最大的市場 | 北美洲 |
儘管市場需求強勁,但該行業仍面臨著與嚴格的監管合規和資料安全要求相關的重大挑戰。無線傳輸高度敏感的患者資訊會造成安全漏洞,因此需要強大的加密技術和遵守複雜的安全通訊協定。這些嚴格的核准流程通常會導致更長的研發週期和更高的製造成本,這可能會阻礙這些技術在預算緊張的醫療保健系統中快速商業化和部署。
感測器小型化和無線技術的顯著進步正在變革腦機介面(BCI),無需笨重的硬體即可實現高頻寬神經資料傳輸。這項技術進步使醫療專業人員和研究人員能夠以最小的侵入性記錄高解析度神經訊號,從而支持用於恢復運動和感覺功能的植入式設備的開發。例如,Neuralink 在 2024 年 9 月的部落格報導「視力恢復設備獲突破性醫療設備認定」中宣布,美國食品藥物管理局(FDA) 已授予其視力恢復植入「突破性醫療設備」認定。這代表著先進無線神經植入領域的一項重要監管成就。這些創新將透過減少患者的身體限制並促進感測器長期融入日常生活,從而將使用者群體擴展到重症監護室之外。
同時,針對在傳統臨床環境之外管理精神和慢性神經系統疾病的遠端監測解決方案的需求日益成長。居家照護的興起推動了對無線治療技術的投資,這些技術能夠提供持續的刺激和數據收集,用於治療諸如難治性憂鬱症疾病。為了體現這一趨勢,Motif Neurotech 在 2024 年 1 月的新聞稿中宣布,已完成 1,875 萬美元的 A 輪資金籌措,以加速開發用於居家精神健康治療的超小型無線植入。此外,Precision Neuroscience 在 2024 年也展示了其技術進步,包括使用其「第七層皮層介面」透過 4096 個電極成功記錄人類腦神經活動,證明了未來監測系統能夠達到的高精度。
嚴格的資料安全和監管合規要求對全球無線腦感測器市場的擴張構成重大障礙。由於這些設備以無線方式傳輸高度敏感的顱內數據,因此本身就存在安全漏洞,需要軍用級加密和廣泛的臨床檢驗。製造商面臨複雜的核准流程,這往往導致研發週期延長和生產成本增加。這些財務和時間壓力迫使企業將資源從創新轉移到合規,導致先進技術的發布延遲,並提高了新進入者的進入門檻。
醫療機構運作中的謹慎態度進一步加劇了這項挑戰的嚴峻性。醫院越來越擔心部署連網無線設備,因為這些設備可能成為網路威脅的入口,因此他們傾向於優先考慮網路安全,而不是部署新的診斷設備。這種擔憂並非空穴來風,因為網路威脅正在不斷升級。根據美國醫院協會 (AHA) 發布的《2025 年報告》,上年度醫療產業提交了 592 份關於受保護醫療資訊被駭客攻擊的監管報告,受影響人數高達創紀錄的 2.59 億。如此大量的安全漏洞迫使採購團隊實施嚴格的篩選程序,進而減緩了無線腦感測器的普及和市場擴張。
將人工智慧 (AI) 整合到即時神經分析中,無需侵入式植入設備即可解碼複雜的神經模式,徹底革新了訊號處理。機器學習演算法現在可以解讀使用無創技術記錄的高維腦活動,並將抽象的神經訊號轉化為快速、可操作的文字。這項進步克服了外部感測器訊號雜訊這一長期存在的難題,從而實現了更可靠的使用者介面。例如,Allwork.Space 於 2025 年 4 月發表的報導《Meta 的新型 AI 技術解讀職場思維》的文章報道稱,Meta 的非侵入式 AI 系統在一項涉及 35 名參與者的研究中,成功地根據腦活動預測了輸入字符,準確率高達 80%。
同時,隨著耳用腦電圖(EEG)和智慧穿戴裝置的興起,腦電感測技術正從臨床實驗室走向便利的消費級穿戴裝置。透過將乾電極感測器整合到耳機中,製造商避免了傳統頭戴式腦電帽的不便,從而能夠在日常環境中持續監測睡眠健康和認知狀態。這種發展趨勢正在推動用戶持續接受此類產品,並在重症監護以外的健康市場創造新的商機。根據《未來主義今日》(The Futurism Today)2025年11月的一篇報導報道,NextSense公司完成了1,600萬美元的A資金籌措,旨在將能夠提供臨床級腦電圖資料的消費級耳塞商業化。
The Global Wireless Brain Sensors Market is projected to expand from USD 560.55 million in 2025 to USD 951.02 million by 2031, achieving a compound annual growth rate of 9.21%. These specialized medical instruments are engineered to track intracranial pressure and neural electrical activity without requiring physical connections to external machinery. The sector is chiefly propelled by the rising global incidence of neurological conditions and the resulting necessity for ambulatory, continuous patient monitoring systems that facilitate home-based healthcare. The critical demand for sophisticated diagnostic solutions is substantiated by the massive global disease burden; the World Health Organization reported in 2024 that neurological disorders impacted over 3 billion individuals globally, ranking as the primary cause of disability and illness.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 560.55 MIllion |
| Market Size 2031 | USD 951.02 MIllion |
| CAGR 2026-2031 | 9.21% |
| Fastest Growing Segment | Dementia |
| Largest Market | North America |
Despite robust market demand, the industry faces substantial hurdles related to strict regulatory compliance and data security mandates. The wireless transfer of confidential patient information creates vulnerabilities that demand robust encryption and compliance with intricate safety protocols. These rigorous approval procedures often lead to prolonged development phases and higher manufacturing costs, which can hinder the swift commercialization and implementation of these technologies within healthcare systems operating under constrained budgets.
Market Driver
Significant progress in sensor miniaturization and wireless technologies is transforming brain-computer interfaces (BCIs), enabling high-bandwidth neural data transmission without the need for bulky hardware. This technological advancement allows medical professionals and researchers to record high-resolution neural signals with minimal invasiveness, supporting the creation of implantable devices capable of restoring motor or sensory functions. For instance, Neuralink announced in a September 2024 blog post regarding the 'Blindsight Breakthrough Device Designation' that the US FDA had awarded breakthrough device status to their vision-restoring implant, marking a critical regulatory achievement for sophisticated wireless neural implants. These innovations alleviate physical constraints on patients and promote long-term sensor integration into daily life, widening the user base beyond intensive care settings.
Concurrently, there is a growing demand for remote monitoring solutions tailored to managing mental health disorders and chronic neurological conditions outside conventional clinical environments. This transition towards home care is driving investments in wireless therapeutics that provide continuous stimulation and data collection for treating conditions like treatment-resistant depression. Highlighting this trend, Motif Neurotech revealed in a January 2024 press release that they had raised USD 18.75 million in Series A funding to further their miniature wireless implant for at-home mental health therapy. Additionally, Precision Neuroscience demonstrated technical progress in 2024 when their Layer 7 Cortical Interface recorded neural activity using 4,096 electrodes on a human brain, proving the high fidelity now attainable for future monitoring systems.
Market Challenge
Stringent requirements for data security and regulatory compliance pose a significant obstacle to the expansion of the Global Wireless Brain Sensors Market. Because these devices wirelessly transmit sensitive intracranial data, they create inherent vulnerabilities that necessitate military-grade encryption and extensive clinical validation. Manufacturers face a convoluted approval environment that frequently results in prolonged development schedules and increased production expenses. These financial and time-related pressures compel companies to shift resources from innovation to compliance tasks, thereby delaying the release of advanced technologies and creating high entry barriers for new competitors.
The severity of this challenge is intensified by operational caution within healthcare facilities. Hospitals are becoming increasingly wary of integrating interconnected wireless devices that might act as gateways for cyber threats, prioritizing network security over the adoption of new diagnostic instruments. This concern is justified by the growing threat landscape; according to the American Hospital Association in 2025, the healthcare industry filed 592 regulatory reports concerning hacks of protected health information during the prior year, impacting a record 259 million people. This massive number of security breaches forces procurement teams to implement strict vetting procedures, which directly slows the uptake and market expansion of wireless brain sensors.
Market Trends
The incorporation of Artificial Intelligence into real-time neural analytics is revolutionizing signal processing by facilitating the decoding of intricate neural patterns without the need for invasive implants. Machine learning algorithms can now interpret high-dimensional brain activity recorded through non-invasive techniques, converting abstract neural signals into actionable text at high speeds. This advancement resolves the long-standing issue of signal noise in external sensors, enabling more dependable user interfaces. For example, an April 2025 article by Allwork.Space titled 'Meta's New AI Tech Can Read Your Mind At Work' reported that Meta's non-invasive AI system achieved 80% accuracy in predicting typed characters from brain activity in a study with 35 participants.
At the same time, the rise of Ear-EEG and smart hearable designs is shifting brain sensing technology from clinical laboratories to discreet consumer wearables. By integrating dry-electrode sensors into earbuds, manufacturers are circumventing the usability challenges associated with traditional scalp caps, thereby enabling continuous monitoring of sleep health and cognitive states in everyday settings. This evolution promotes user adherence and creates new revenue opportunities in wellness markets outside of critical care. As noted in a November 2025 article by The Futurism Today, NextSense closed a USD 16 million Series A funding round to bring their consumer-grade EEG earbuds, designed to provide clinical-quality insights, to the commercial market.
Report Scope
In this report, the Global Wireless Brain Sensors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Wireless Brain Sensors Market.
Global Wireless Brain Sensors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: